Malaysia's Pharmaniaga signs Covid vaccine agreement with China's Sinovac
[KUALA LUMPUR] Malaysia Pharmaniaga has signed an agreement with China's Sinovac to purchase ready-to-fill Covid-19 vaccines and later to manufacture the vaccine domestically, it said on Tuesday.
Pharmaniaga said in a filing to the bourse that the company will carry out a fill-and-finish process of the vaccine in Malaysia, and will subsequently enter into local manufacturing, under license from Sinovac for its technology and know-how.
"This will also help Pharmaniaga in long-term partnerships, including technology transfer to grow the sector in Malaysia," the company said.
Malaysia has been in talks to secure a total of 23.9 million doses of Covid-19 vaccines from Sinovac and another Chinese manufacturer CanSino Biologics, and from Russia's Gamaleya Institute, the maker of the Sputnik V vaccine.
The South-east Asian nation has also procured coronavirus vaccines from US and German drugmakers Pfizer and BioNTech, as well as British-Swedish biopharmaceutical firm AstraZeneca.
REUTERS
A NEWSLETTER FOR YOU
Asean Business
Business insights centering on South-east Asia's fast-growing economies.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Philippines’ Recto sees rate-cut delay risk if peso sinks to 59
Ecuador president declares state of emergency over energy crisis
US Senate has agreement on Fisa reauthorisation, will vote on Friday night, Schumer says
US expects to finalise new Aukus trade exemptions in next 120 days
IMF concerned about debt, fiscal challenges facing low-income countries
Bank of Japan’s Ueda says ‘very likely’ to hike rates if inflation keeps rising